SGLT-2 inhibitor for the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or hyperglycemia

摘要

The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.